Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Kombo

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Chemical Information and Modeling|December 17, 2013
Comparative study on the use of docking and Bayesian categorization to predict ligand binding to nicotinic acetylcholine receptors (nAChRs) subtypesDavid C Kombo, Merouane Bencherif
Journal of Medicinal Chemistry|May 26, 2025
The Logic of Chemical OptimizationDavid C Kombo, Matthew J LaMarche
Proteins|May 29, 2024
Application of artificial intelligence and machine learning techniques to the analysis of dynamic protein sequencesDavid C Kombo, Matthew J LaMarche, Chilaluck C Konkankit, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2013
Computational studies of novel carbonyl-containing diazabicyclic ligands interacting with α4β2 nicotinic acetylcholine receptor (nAChR) reveal alternative binding modesDavid C Kombo, Anatoly A Mazurov, Jon-Paul Strachan, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2013
QM-polarized ligand docking accurately predicts the trend in binding affinity of a series of arylmethylene quinuclidine-like derivatives at the α4β2 and α3β4 nicotinic acetylcholine receptors (nAChRs)David C Kombo, Vladimir P Grinevich, Terry A Hauser, et al.
Journal of Chemical Information and Modeling|December 19, 2012
3D molecular descriptors important for clinical successDavid C Kombo, Kartik Tallapragada, Rachit Jain, et al.
Bioorganic & Medicinal Chemistry Letters|May 23, 2013
Novel nicotinic acetylcholine receptor agonists containing carbonyl moiety as a hydrogen bond acceptorAnatoly A Mazurov, David C Kombo, Srinivasa Akireddy, et al.
ACS Omega|July 8, 2024
Predictions of Colloidal Molecular Aggregation Using AI/ML ModelsDavid C Kombo, J David Stepp, Sungtaek Lim, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2011
Discovery of novel α7 nicotinic acetylcholine receptor ligands via pharmacophoric and docking studies of benzylidene anabaseine analogsDavid C Kombo, Anatoly A Mazurov, Joseph Chewning, et al.
European Journal of Medicinal Chemistry|August 23, 2014
Identification and pharmacological characterization of 3,6-diazabicyclo[3.1.1]heptane-3-carboxamides as novel ligands for the α4β2 and α6/α3β2β3 nicotinic acetylcholine receptors (nAChRs)Jon-Paul Strachan, David C Kombo, Anatoly Mazurov, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Chemical Information and Modeling|December 17, 2013
Comparative study on the use of docking and Bayesian categorization to predict ligand binding to nicotinic acetylcholine receptors (nAChRs) subtypesDavid C Kombo, Merouane Bencherif
Journal of Medicinal Chemistry|May 26, 2025
The Logic of Chemical OptimizationDavid C Kombo, Matthew J LaMarche
Proteins|May 29, 2024
Application of artificial intelligence and machine learning techniques to the analysis of dynamic protein sequencesDavid C Kombo, Matthew J LaMarche, Chilaluck C Konkankit, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2013
Computational studies of novel carbonyl-containing diazabicyclic ligands interacting with α4β2 nicotinic acetylcholine receptor (nAChR) reveal alternative binding modesDavid C Kombo, Anatoly A Mazurov, Jon-Paul Strachan, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2013
QM-polarized ligand docking accurately predicts the trend in binding affinity of a series of arylmethylene quinuclidine-like derivatives at the α4β2 and α3β4 nicotinic acetylcholine receptors (nAChRs)David C Kombo, Vladimir P Grinevich, Terry A Hauser, et al.
Journal of Chemical Information and Modeling|December 19, 2012
3D molecular descriptors important for clinical successDavid C Kombo, Kartik Tallapragada, Rachit Jain, et al.
Bioorganic & Medicinal Chemistry Letters|May 23, 2013
Novel nicotinic acetylcholine receptor agonists containing carbonyl moiety as a hydrogen bond acceptorAnatoly A Mazurov, David C Kombo, Srinivasa Akireddy, et al.
ACS Omega|July 8, 2024
Predictions of Colloidal Molecular Aggregation Using AI/ML ModelsDavid C Kombo, J David Stepp, Sungtaek Lim, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2011
Discovery of novel α7 nicotinic acetylcholine receptor ligands via pharmacophoric and docking studies of benzylidene anabaseine analogsDavid C Kombo, Anatoly A Mazurov, Joseph Chewning, et al.
European Journal of Medicinal Chemistry|August 23, 2014
Identification and pharmacological characterization of 3,6-diazabicyclo[3.1.1]heptane-3-carboxamides as novel ligands for the α4β2 and α6/α3β2β3 nicotinic acetylcholine receptors (nAChRs)Jon-Paul Strachan, David C Kombo, Anatoly Mazurov, et al.
Pageof 2